1.1 Fatigue (end of treatment) |
7 |
840 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.66 [‐1.01, ‐0.31] |
1.2 Fatigue (follow‐up) |
4 |
670 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.62 [‐1.32, 0.07] |
1.3 Participants with serious adverse reactions |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
1.4 Pain (follow‐up) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.4.1 Brief Pain Inventory, pain severity subscale (0 to 10 points) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.4.2 Brief Pain Inventory, pain interference subscale (0 to 10 points) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.5 Physical functioning (end of treatment) |
5 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.5.1 SF‐36, physical functioning subscale (0 to 100 points) |
5 |
725 |
Mean Difference (IV, Random, 95% CI) |
‐13.10 [‐24.22, ‐1.98] |
1.6 Physical functioning (follow‐up) |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.6.1 SF‐36, physical functioning subscale (0 to 100 points) |
3 |
621 |
Mean Difference (IV, Random, 95% CI) |
‐16.33 [‐36.74, 4.08] |
1.7 Quality of life (follow‐up) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.7.1 Quality of Life Scale (16 to 112 points) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.8 Depression (end of treatment) |
5 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.8.1 HADS, depression score (7 items/21 points) |
5 |
504 |
Mean Difference (IV, Random, 95% CI) |
‐1.63 [‐3.50, 0.23] |
1.9 Depression (follow‐up) |
4 |
654 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.35 [‐0.93, 0.23] |
1.10 Anxiety (end of treatment) |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.10.1 HADS, anxiety score (0 to 21 points) |
3 |
387 |
Mean Difference (IV, Random, 95% CI) |
‐1.48 [‐3.58, 0.61] |
1.11 Anxiety (follow‐up) |
4 |
652 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.17 [‐0.50, 0.15] |
1.12 Sleep (end of treatment) |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.12.1 Jenkins Sleep Scale (0 to 20 points) |
2 |
323 |
Mean Difference (IV, Random, 95% CI) |
‐1.49 [‐2.95, ‐0.02] |
1.13 Sleep (follow‐up) |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.13.1 Jenkins Sleep Scale (0 to 20 points) |
3 |
610 |
Mean Difference (IV, Random, 95% CI) |
‐2.04 [‐3.84, ‐0.23] |
1.14 Self‐perceived changes in overall health (end of treatment) |
4 |
489 |
Risk Ratio (M‐H, Random, 95% CI) |
1.83 [1.39, 2.40] |
1.15 Self‐perceived changes in overall health (follow‐up) |
3 |
518 |
Risk Ratio (M‐H, Random, 95% CI) |
1.88 [0.76, 4.64] |
1.16 Health resource use (follow‐up) (Mean no. of contacts) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.16.1 Primary care |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.16.2 Other doctor |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.16.3 Healthcare professional |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.16.4 Inpatient |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.16.5 Accident and emergency |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.16.6 Other health/social services |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.16.7 Complementary health care |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.16.8 Standardised medical care |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
1.17 Health resource use (follow‐up) (No. of users) |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
1.17.1 Primary care |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
1.17.2 Other doctor |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
1.17.3 Healthcare professional |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
1.17.4 Inpatient |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
1.17.5 Accident and emergency |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
1.17.6 Medication |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
1.17.7 Complementary health care |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
1.17.8 Other health/social services |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
1.17.9 Standardised medical care |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
1.18 Dropout |
6 |
843 |
Risk Ratio (M‐H, Random, 95% CI) |
1.63 [0.77, 3.43] |
1.19 Sensitivity analysis for fatigue (end of treatment) |
7 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.19.1 Fatigue Scale, FS (11 items/0 to 11 points) |
2 |
325 |
Mean Difference (IV, Random, 95% CI) |
‐3.50 [‐8.53, 1.53] |
1.19.2 Fatigue Scale, FS (11 items/0 to 33 points) |
2 |
363 |
Mean Difference (IV, Random, 95% CI) |
‐2.57 [‐4.04, ‐1.10] |
1.19.3 Fatigue Scale, FS (14 items/0 to 42 points) |
3 |
152 |
Mean Difference (IV, Random, 95% CI) |
‐6.80 [‐10.31, ‐3.28] |
1.20 Sensitivity analysis for fatigue (follow‐up) |
4 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.20.1 Fatigue Scale, FS (11 items/0 to 11 points) |
1 |
148 |
Mean Difference (IV, Random, 95% CI) |
‐7.13 [‐7.97, ‐6.29] |
1.20.2 Fatigue Scale, FS (11 items/0 to 33 points) |
2 |
472 |
Mean Difference (IV, Random, 95% CI) |
‐2.87 [‐4.18, ‐1.55] |
1.20.3 Fatigue Severity Scale, FSS (9 items/1 to 7 points) |
1 |
50 |
Mean Difference (IV, Random, 95% CI) |
0.15 [‐0.55, 0.85] |
1.21 Subgroup analysis for fatigue (end of treatment) |
7 |
840 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.66 [‐1.01, ‐0.31] |
1.21.1 Graded exercise therapy |
6 |
779 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.68 [‐1.08, ‐0.28] |
1.21.2 Exercise with self‐pacing |
1 |
61 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.54 [‐1.05, ‐0.02] |
1.22 Subgroup analysis for fatigue (follow‐up) |
4 |
670 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.62 [‐1.32, 0.07] |
1.22.1 Graded exercise therapy |
3 |
620 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.85 [‐1.67, ‐0.03] |
1.22.2 Anaerobic exercise |
1 |
50 |
Std. Mean Difference (IV, Random, 95% CI) |
0.12 [‐0.44, 0.67] |
1.23 Sensitivity analysis for depression (follow‐up) |
4 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.23.1 Beck Depression Inventory (0 to 63 points) |
1 |
45 |
Mean Difference (IV, Random, 95% CI) |
3.44 [‐3.00, 9.88] |
1.23.2 HADS, depression subscale (0 to 21 points) |
3 |
609 |
Mean Difference (IV, Random, 95% CI) |
‐2.26 [‐5.09, 0.56] |
1.24 Sensitivity analysis for anxiety (follow‐up) |
4 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.24.1 Beck Anxiety Inventory (0 to 63 points) |
1 |
45 |
Mean Difference (IV, Random, 95% CI) |
0.70 [‐4.52, 5.92] |
1.24.2 HADS, anxiety score (0 to 21 points) |
3 |
607 |
Mean Difference (IV, Random, 95% CI) |
‐1.01 [‐2.75, 0.74] |